Machine learning-based investigation of regulated cell death for predicting prognosis and immunotherapy response in glioma patients

Abstract excerpt

Glioblastoma is a highly aggressive and malignant type of brain cancer that originates from glial cells in the brain, with a median survival time of 15 months and a 5-year survival rate of less than 5%. Regulated cell death (RCD) is the autonomous and orderly cell death under genetic control, controlled by precise signaling pathways and molecularly defined effector mechanisms, modulated by pharmacological or...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ferroptosis and cancer prognosis
• Share to Glioma Diagnosis and Treatment
• Share to Neuroinflammation and Neurodegeneration Mechanisms